References
- Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372:241–248.
- Hawton K, Bergen H, Simkin S, et al. Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: time-series study. PLoS Med. 2012;9:e1001213.
- Spiller HA, Gorman SE, Villalobos D, et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol. 1997;35:361–364.
- Marquardt KA, Alsop JA, Albertson TE. Tramadol exposures reported to statewide poison control system. Ann Pharmacother. 2005;39:1039–1044.
- Shadnia S, Soltaninejad K, Heydari K, et al. Tramadol intoxication: a review of 114 cases. Hum Exp Toxicol. 2008;27:201–205.
- Farajidana H, Hassanian-Moghaddam H, Zamani N, et al. Tramadol-induced seizures and trauma. Eur Rev Med Pharmacol Sci. 2012;16:34–37.
- Thundiyil JG, Kearney TE, Olson KR. Evolving epidemiology of drug-induced seizures reported to a poison control center system. J Med Toxicol. 2007;3:15–19.
- Jovanović-Cupić V, Martinović Z, Nesić N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol.2006;44:143–146.
- Talaie H, Panahandeh R, Fayaznouri M, et al. Dose-independent occurrence of seizure with tramadol. J Med Toxicol. 2009;5:63–67.
- Taghaddosinejad F, Mehrpour O, Afshari R, et al. Factors related to seizure in tramadol poisoning and its blood concentration. J Med Toxicol. 2011;7:183–188.
- Eizadi-Mood N, Ozcan D, Sabzghabaee AM, et al. Does naloxone prevent seizure in tramadol intoxicated patients? Int J Prev Med. 2014;5:302–307.
- Tashakori A, Afshari R. Tramadol overdose as a cause of serotonin syndrome: a case series. Clin Toxicol.2010;48:337–431.
- Shadnia S, Brent J, Mousavi-Fatemi K, et al. Recurrent seizures in tramadol intoxication: implications for therapy based on 100 patients. Basic Clin Pharmacol Toxicol. 2012;111:133–136.
- Farzaneh A, Mostafazade B, Mehrpur O. Seizorugenic effects of low-dose naloxone in tramadol overdose. Iran J Pharmacol Ther. 2012;11:6–9.
- Saidi H, Ghadiri M, Abbasi S, et al. Efficacy and safety of naloxone in the management of postseizure complaints of tramadol intoxicated patients: a self-controlled study. Emerg Med J. 2010;27:928–930.
- Hassanian-Moghaddam H, Farnaghi F, Rahimi M. Tramadol overdose and apnea in hospitalized children, a review of 20 cases. Res Pharm Sci. 2015;10:544–552.
- Stassinos GL, Gonzales L, Klein-Schwartz W. Characterizing the toxicity and dose-effect profile of tramadol ingestions in children. Pediatr Emerg Care. 2017 [Feb 21]. DOI:10.1097/PEC.0000000000001084
- Hassanian-Moghaddam H, Farajidana H, Sarjami S, et al. Tramadol-induced apnea. Am J Emerg Med. 2013;31:26–31.
- Fujimoto Y, Funao T, Suehiro K, et al. Brain serotonin content regulates the manifestation of tramadol-induced seizures in rats: disparity between tramadol-induced seizure and serotonin syndrome. Anesthesiology. 2015;122:178–189.
- Lagard C, Chevillard L, Malissin I, et al. Mechanisms of tramadol-related neurotoxicity in the rat: Does diazepam/tramadol combination play a worsening role in overdose? Toxicol Appl Pharmacol. 2016;310:108–119.
- Rehni AK, Singh I, Kumar M. Tramadol-induced seizurogenic effect: a possible role of opioid-dependent gamma-aminobutyric acid inhibitory pathway. Basic Clin Pharmacol Toxicol. 2008;103:262–266.
- Rehni AK, Singh TG, Singh N, et al. Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine H1 receptor activation-linked mechanism. Naunyn-Schmied Arch Pharmacol. 2010;381:11–19.
- Clarot F, Goullé J, Vaz E, et al. Fatal overdoses of tramadol: is benzodiazepine a risk factor of lethality? Forensic Sci Int. 2003;134:57–61.
- Pirnay SO, Mégarbane B, Borron SW, et al. Effects of various combinations of benzodiazepines with buprenorphine on arterial blood gases in rats. Basic Clin Pharmacol Toxicol. 2008;103:228–239.
- Racine RJ. Modification of seizure activity by electrical stimulation. I. After-discharge thresholdElectroencephalogr Clin Neurophysiol. 1972;32:269–299.
- Bartlett DJ, Tenney S. Control of breathing in experimental anemia. Respir Physiol. 1970;10:384–395.
- Beaune S, Callebert J, Baud FJ, et al. Mechanisms of high-dose citalopram-induced death in a rat model. Toxicology. 2012;302:248–254.
- Haglind E. Effects of continuous naloxone infusion in intestinal ischemia shoch in the rat. Circ Shok. 1992;32:269–299.
- Tallarida R, Murray RB, Area under a curve: Simpson’s rule and trapezoidal rule. In: Tallarida R, Murray RB, editors. Manual of pharmacology calculations with computer programs. New York (NY): Springer-Verlag; 1981. p. 47–49.
- Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43:879–923.
- Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367:146–155.
- Gilbert PE, Martin WR. Antagonism of the convulsant effects of heroin, d-propoxyphene, meperidine, normeperidine and thebaine by naloxone in mice. J Pharmacol Exp Ther. 1975;192:538–541.
- Yang L, Li F, Ge W, et al. Protective effects of naloxone in two-hit seizure model. Epilepsia. 2010;51:344–353.
- Omrani A, Ghadami MR, Fathi N, et al. Naloxone improves impairment of spatial performance induced by pentylenetetrazol kindling in rats. Neuroscience. 2007;145:824–821.
- Raffa RB, Stone DJ. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice. J Pharmacol Exp Ther. 2008;325:500–506.
- Buajordet I, Naess AC, Jacobsen D, et al. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med. 2004;11:19–23.
- Wermeling DP. Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access. Ther Adv Drug Saf. 2015;6:20–31.
- Schaeffer JI, Haddad GG. Ventilatory response to moderate and severe hypoxia in adult dogs: role of endorphins. J Appl Physiol. 1988;65:1383–1388.
- Schlenker EH, Inamdar SR. Effects of naloxone on oxygen consumption and ventilation in awake golden Syrian hamsters. Physiol Behav. 1995;57:655–658.
- Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16:48–61.